Health9/30/2026•NYT

Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.

Source: For the complete article, please visit the original source link below.

Source: NYTEnhanced summary
Share:
Read full story ↗More in Health

Related Articles

Ben Jennings on Andy Burnham’s pledge to overhaul social care – cartoon
🏥 Health9h ago•1 min read

Ben Jennings on Andy Burnham’s pledge to overhaul social care – cartoon

Source: The Guardian
Endometriosis trial gives hope to millions of women in pain like me
🏥 Health9h ago•1 min read

Endometriosis trial gives hope to millions of women in pain like me

Source: BBC
Andy Burnham’s social care plans could be much more radical | Letter
🏥 Health9h ago•1 min read

Andy Burnham’s social care plans could be much more radical | Letter

Source: The Guardian
NYT logo
🏥 Health11h ago•1 min read

Medical Records Firm Uses AI Tool to Expose Flaws that Threaten Patient Privacy

Source: NYT
More than 44,000 file legal objections to Palantir NHS platform handling their data
🏥 Health11h ago•1 min read

More than 44,000 file legal objections to Palantir NHS platform handling their data

Source: The Guardian
How Europe’s housing crisis is fuelling a new movement
🏥 Health12h ago•1 min read

How Europe’s housing crisis is fuelling a new movement

Source: The Guardian